TriSalus: SD-101 and SmartValve Technology

Proceedings of the Special Interest Group on Computer Graphics and Interactive Techniques Conference: Electronic Theater Pub Date : 2023-07-27 DOI:10.1145/3577024.3588877

D. Ehlert, Joshua Bird, D. Bergey, Valerie Bentivegna, Brandon Keehner, R. Milner, Rachel Simons

引用次数: 0

Abstract

TriSalus's investigational therapeutic candidate SD-101 has the potential to reprogram or eliminate immunosuppressive cells and enable immunotherapy in liver tumors.

查看原文本刊更多论文

TriSalus: SD-101和SmartValve技术

TriSalus的研究候选治疗药物SD-101具有重编程或消除免疫抑制细胞的潜力，可用于肝脏肿瘤的免疫治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Proceedings of the Special Interest Group on Computer Graphics and Interactive Techniques Conference: Electronic Theater

自引率

0.00%

发文量